Elanco Animal Health Raises FY2026 Adj EPS Guidance from $1.10-$1.16 to $1.17-$1.20 vs $1.13 Est; Raises FY2026 Sales Guidance from $5.090B-$5.140B to $5.155B-$5.180B vs $5.132B Est
Elanco Animal Health (NYSE:ELAN) raises FY2026 Adj EPS guidance from $1.10-$1.16 to $1.17-$1.20 vs $1.13 analyst estimate. Raises FY2026 sales outlook from $5.090 billion-$5.140 billion to $5.155 billion-$5.180 billion
Elanco said it will make more money and sell more stuff than it thought before. When a company raises its own forecast, watch if it keeps delivering on those bigger promises.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.